製品の概要

  • 製品名
    HENECA
  • 製品の詳細
    Selective A2A receptor agonist
  • 生理活性の詳細
    Selective A2A receptor agonist (Ki = 2.2 nM). Shows good selectivity for A2A over A1 receptors. Displays antiaggregatory activity. Increases cAMP accumulation (EC50 = 43 nM) and inhibits superoxide anion production (EC50 = 3.63 nM) in neutrophils.
  • 精製度
    > 99%

製品の特性

参考文献

This product has been referenced in:
  • Varani K  et al. Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. Br J Pharmacol 136:57-66 (2002). Read more (PubMed: 11976268) »
  • Varani K  et al. Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects. Circulation 102:285-9 (2000). Read more (PubMed: 10899090) »
  • Monopoli A  et al. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine. Arzneimittelforschung 44:1296-304 (1994). Read more (PubMed: 7848347) »

See 1 Publication for this product

レビューと Q&A

There are currently no Customer reviews or Questions for ab120458.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

登録